when do compounding pharmacies have to stop selling semaglutide Compounded Semaglutide: Safety & Regulation Guide FDA Moves to Permanently Close
Description
Preclinical studies in rodents have shown an association between GLP-1 receptor activation and thyroid C-cell changes, although a direct causal link in humans has not been established, and UK/EU SmPCs for authorised GLP-1 RAs do not list MTC or MEN2 as a formal contraindication

But as of February 2, 2026, the regulators have caught up, the manufacturers have built their factories, and the safe harbors that protected your business have largely evaporated

In addition, those who are overweight and have had difficulty losing weight through diet and exercise alone may also be considered

GIP receptor: Boosts meal-stimulated insulin and can influence fat storage, affecting how the body handles calories

They dont accept refunds on medications that have been shipped
